scispace - formally typeset
Patent

4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines

Reads0
Chats0
TLDR
In this paper, 4.4-[(Bicyclic heterocyclyl)methyl and -hetero]-piperidines having antihistaminic and serotonin-antagonistic properties are useful agents in the treatment of allergic diseases.
Abstract
4-[(Bicyclic heterocyclyl)methyl and -hetero]-piperidines having antihistaminic and serotonin-antagonistic properties which compounds are useful agents in the treatment of allergic diseases.

read more

Citations
More filters
Patent

Quinazoline derivatives as medicaments

TL;DR: In this article, a method to inhibit TGF-β and/or p38-α kinase using compounds of formula (1) or the pharmaceutically acceptable salts thereof was proposed.
Patent

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

TL;DR: In this article, the authors describe modulators of CCR3 of formula (I) or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
Patent

Respiratory syncytial virus replication inhibitors

TL;DR: In this article, the compounds of formula (I), prodrugs, Noxides, addition salts, quaternary amines, metal complexes or stereochemically isomeric forms thereof are defined.
Patent

1,2-benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives

TL;DR: In this paper, the authors proposed a novel 3-piperidinyl-1,2-benzisothiazoles and 1-2-bensisoxazoles having the formula wherein X is O or S and Q is a radical of formula or a radical-of-formula, and possible stereochemically isomeric forms thereof.
Patent

2-aminopyrimidinone derivatives

TL;DR: Amino-pyrimidininone derivatives possessing antihistaminic and serotonin-antagonistic properties were used as the active ingredient of compositions containing these compounds as the effective ingredient and a method of treating subjects from allergic diseases as mentioned in this paper.
References
More filters
Patent

Piperidinylalkyl quinazoline compounds, composition and method of use

TL;DR: Novel quinazoline derivatives, comprising in the heterocyclic part of their nucleus at least one carbonyl or thiocarbonyl group and a particularly substituted piperidinyl-alkyl side chain, have been found to be potent serotonin-antagonists as discussed by the authors.
Patent

N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives

TL;DR: Novel N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives having antihistaminic properties which compounds are useful in the treatment of allergic diseases.
Patent

N-(Bicyclic heterocyclyl)-4-piperidinamines

TL;DR: Novel N-(bicyclic heterocyclyl)-4-piperidinamines having antihistaminic and serotonin-antagonistic properties which are useful in the treatment of allergic diseases as mentioned in this paper.
Patent

N-Heterocyclyl-4-piperidinamines

TL;DR: In this article, N-heterocyclyl-4-piperidinamines where the heterocyclic radical is an optionally substituted 1H-benzimidazol-2-yl or 3H-imidazo[4,5b]pyridin-2yl radical, said compounds being useful as antihistaminic agents.
Patent

Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines

TL;DR: Bicyclic heterocyclyl containing 4-piperidinamines have antihistaminic and serotonin-antagonistic properties which compounds are useful agents in the treatment of allergic diseases as mentioned in this paper.
Related Papers (5)